0001127602-24-013976.txt : 20240502 0001127602-24-013976.hdr.sgml : 20240502 20240502162217 ACCESSION NUMBER: 0001127602-24-013976 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240430 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guindo Chirfi CENTRAL INDEX KEY: 0001722753 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 24908701 MAIL ADDRESS: STREET 1: C/O BIOGEN INC. STREET 2: 225 BINNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-04-30 0000310158 Merck & Co., Inc. MRK 0001722753 Guindo Chirfi MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY NJ 07065 1 Chief Marketing Officer 0 Common Stock 20753.241 D Common Stock-401(k) Plan 53.4868 I By 401(k) Stock Option (Right to Buy) 129.22 2024-04-30 4 A 0 29297 0 A 2025-04-30 2034-04-29 Common Stock 29297 29297 D Holdings include shares acquired in dividend reinvestment transactions. Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan. The option vests and becomes exercisable in equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. /s/ Kelly Grez, as attorney-in-fact for Mr. Chirfi Guindo 2024-05-02